SlideShare a Scribd company logo
Dr. kiran G.piparva
Assistant professor, Pharmacology
department
P
. D. U. Government medical
college, Rajkot
Contents……
• Introduction
• Chemical structure
• Classification
• Antibacterial spectrum
• Mechanism of action
• Mechanism of resistance
• Individual drugs
• Synthetic antimicrobial agent
• Having quinolone structure
• Primarily active against gram negative
bacteria
• First member is NALIDIXIC ACID
Breakthrough 1980-
• Fluorination of quinolone
structure at 6th position and
addition of piperazine at 7th
position resulting derivative
called-
“FLUROQUINOLONES”
Development of FQs……
• 1960s – Nalidixic acid
• 1970s – Cinoxacin and Rosoxcin
• 1980s – Norfloxacin , Ciprofloxacin, Ofloxacin
• 1990s – Lomefloxacin, Sparfloxacin
• 2000s – Lovofloxacin, Gatifloxacin, Trovafloxacin , Moxifloxacin,
Gemifloxacin
FQs
First
generation
One FLUORO
substitution
Effective against
gram-ve organism
Second
generation
- ADDITIONAL
FLUORO and other
substitutions ..
Antimicrobial
spectrum extendto gram
+ve and anaerobes
FQs
First generation
Norfloxacin,
Ciprofloxacin
Pefloxacin
Ofloxacin
Second generation
Levofloxacin,
Lomefloxacin
Sparfloxacin
Gemifloxacin
Moxifloxacin
prulifloxacin
Pazufloxacin and Balofloxacin in india
Bacterial DNA gyrase
Subunit B
Subunit A
Site of action
Mechanism of action of FQ….
Positive supercoiling
Negative supercoiling
Mechanism of action of FQ
Gram -ve Gram +ve
 Less likely & very slow to
develop
 Reduced permeability
 Increased efflux
 Chromosomal mutation
producing a DNA gyrase/
topoisomerase IV with
reduced affinity for FQs.
Mechanism of Resistant
•For individual drugs… DIFFERENCES….
• Antimicrobial spectrum
• Pharmacokinetic profile
• ADR
CIPROFLOXACIN (prototype)
• Most potent 1st generation FQ
• Spectrum :
• Aerobic gram – ve bacilli-
Enterobacteriaceae and Neisseria
Antibiotic spectrum
 Higley susceptible
Gram -ve bacilli Gram -ve cocci
-E.Coli - Neisseria
-Salmonella -H. influenzae
-Shigella -H, ducreyi
-Proteus -Compylobector
- K. pneumoniae jejuni
 Moderately susceptible
-Atypical organisms
-Pseudomonas aeruginosa
- Anthracis
- Brucella
- Chlamydia pneumophila
- Listeria
- Mycoplasma
- Mycobacterium
- Staph epidermidis
Low or variable
susceptibility (gm+Ve)
- Strep. Pyrogens
- Strep. Faecalis
- Strep. Pneumoniae
- MRSA
- Mycobact. Kansasii
- MAC
RESISTANT : ANAEROBES
Pharmacokinetics
• Absorption: good with empty
stomach
• Good tissue penetrability
• Renal excretion : required dose
reduction in kidney damage
ADR of FQ…
• Good safety record…..Mild ADRs
• GIT: N/V/A, bad taste
• CNS: Dizziness, headache, restlessness,
anxiety, insomnia, impairment of
concentration, dexterity- seizure when high
dose or predisposing factors
• HST: hypersensitivity reaction- rash pruritis,
photosensitivity, urticaria, swellings.
• Tendonitis and tendon rupture: higher in age
above 60yrs, patients receiving corticosteroids.
Children, seizure,
photosensitivity
While driving
C/I : pregnancy
Drug Interactions
• Absorption: Other drugs reduce absorption of FQs : Antacids,
sucralfate and iron salts
• Norfox/ ciproflox/ pefloxacin raises theophylline, caffeine and warfarin
concentration – Second generation are safe
• NSAIDs may enhance the CNS toxicity of FQs; seizures are reported
Important features of FQs………
Bactericidal
Rapid action
Post antibiotic effect
Mutational resistance is low
Susceptible to Penicillin , cephalosporin, aminoglycoside resistant
bacteria
Activity is pH dependent – reduced activity at acidic pH
Therapeutic uses of FQs…..
• Ciprofloxacin is highly effective because…..
 Wide spectrum
 Bactericidal activity
 Oral efficacy
 Good tolerability
 Best for gram –ve infections

EMPIRICAL THERAPY
DOSE:
Gram negative
infections
Urinary track infection
Bacterial gastroenteritis
Typhoid fever
Bone & soft tissue, gynecological and
wound infection
Gram negative septicemia
Conjunctivitis
Gonorrhoea
Meningitis
• Other infections:
• Chancroid
• Anthrax
• Respiratory infection
• Tuberculosis
• Prophylaxis
Therapeutic uses…….
1. Urinary tract infection(UTI)
• FQ are superior to Trimethoprim-sulfamethoxazole
• Good concentration in urine
• High cure rate even in complicated UTI
• All FQ are equally effective
2. Bacterial gastroenteritis:
Empirical therapy- most common
3. Gonorrhoea: 100% curative in PPNG/ NPPNG- not used now
4. Bone soft tissue, gynaecological and wound infection:
high cure rate is obtained with prolonged Rx (6-8wk) with high dose
(750mgBD)
5. Typhoid fever
• First line drugs
• Ciprofloxacin is the drug of choice
• 750mg BD orally or 200mg I.V. 12 hrly for 10-14 days
Other options:
• Ceftriaxone: fastest acting bactericidal, prevent relapse and carrier state,
preferred over FQs in children, pregnant women & FQ resistant cases
• Fluroquinolones: equally efficacious alternative ceftriaxone
• Azithromycin: 2nd line alternative in multidrug resistant typhoid
• Chloramphenicol: Resistant and unreliable
• Cotrimoxazole: Resistant, rarely used.
6. Respiratory infections
• Not as primary drug
• DOC only for Atypical pneumonia due to Mycoplasma, legionella, H.
influenzas, Chlamydia pneumonia
• 2nd generation (Levofloxacin/ Gemifloxacin/ Moxifloxacin) – used
7. Tuberculosis
• Moxifloxacin/ levofloxacin : 2nd line antitubercular drug & for combination drugs
in MDR TB
• Ciprofloxacin most active against MAC
8. Meningitis: Only for gm –ve bacterial meningitis especially in
immunocompromised patients
Properties of 1st generation FQs
• No activity against S. Pneumoniae & anaerobes
• No significant CNS concentration
• Short action – twice daily dosing
• DI: Raises warfarin and theophylline concentration
Common to
Ciproflox/
Oflox /
Pefloxacin
Properties of 2nd generation FQs
• Spectrum: Active against Gm +ve bacteria & anaerobes
• PK: Longer action – OD- good compliance
• CNS concentration is poor
• NO DI: Levoflox/ sparflox do not interact with warfarin and
theophylline
• ADR:
• Prolongs QT interval/ Phototoxicity –
sparflox/gatiflox/moxiflox/gemiflox
• Pefloxacin:
• Better PK- lipid soluble, long t1/2- better CSF concentration
• Metabolized to norfloxacin- dose adjustment required in
liver disease but NOT in renal insufficiency
• Ofloxacin:
• More active on strep. Pyogenes and gram+ve / anaerobes, chlamydia,
Mycoplasma, mycobacterium
• MDR TB: Alternative therapy for multidrug resistant tuberculosis
• Levofloxacin
• Levo isomer of ofloxacin
- Good PK- 100% bioavailability orally – long half life- OD- NO Drug
interaction
- Primary indication:
- CAP- community acquired pneumonia, pyelonephritis, prostatis, skin/ soft
tissue infection
- MDR TB : 2nd line antitubercular drug- combined regimen for MDR TB
• Moxifloxacin:
• MDR TB : Most potent against M. tuberculosis- used in MDR TB
• Should not given to predisposed to seizure- QT prolongation
2nd generation FQs
• Sparfloxacin:
• 2nd generation difluorinated quinolones
• Phototoxic, QT prolongation
• Lomefloxacin
• 2nd generation difluorinated - higher
phototoxicity- Q-T prolongation
• Gemifloxacin:
• Broad spectrum/ aerobic/ resistant orgasnim
• QT prolongation, DI
QT
PROLONGATION,
PHTOTOXICITY
• Prulifloxacin
Prodrug- Good spectrum- Good PK
NO QT - PROLONGATION
• Pazufloxacin:
• Only injectable formulation as “ Mesylate”
• Rarely seizure- limit dose
• Balofloxacin
• Marketed only in India and few other countries
HEPATIC
HEPATIC
Pharmacokinetics
Absorption Distribution Metabolism Elimination
Ciprofloxacin is
well absorbed on
empty stomach
F= 70-95% except
norfloxacin – 40%
Excellent tissue
penetration (lungs,
sputum, prostate ,
muscle, bone)
Poor penetration in
brain and eyes
Pefloxacin and
Moxifloxacin ,
Trovafloxacin are
metabolised by
liver- require dose
reduction in hepatic
dysfunction (PMT)
Most Quinolones are
cleared by kidney -
require dose
reduction in renal
dysfunction
• Clinically significant post antibiotic effect (2-6 hours)
• Sparfloxacin has longest action (18-20 hrs)
• 1st generation drugs given twice a day –
• 2nd generation drugs once only
Some withdrawn FQs
• Gatifloxacin – Dysglycemia
• Lomiflxacin/ sparfloxacin – photosensitivity & QT prolongation
• Trovafloxacin – Hepatotoxicity
• Grepafloxacin – Cardiotoxicity
Fluroquinolones.. Dr. kiran g. piparva
Fluroquinolones.. Dr. kiran g. piparva

More Related Content

What's hot

Quinolones
QuinolonesQuinolones
Quinolones
Ruchita Bhavsar
 
Anti TB drugs and Treatment of tuberculosis satya
Anti TB drugs and Treatment of tuberculosis   satya  Anti TB drugs and Treatment of tuberculosis   satya
Anti TB drugs and Treatment of tuberculosis satya
sathyanarayanan varadarajan
 
Quinolone resistance
Quinolone resistanceQuinolone resistance
Quinolone resistance
SheemaKhanam
 
Fluroquinolones 2
Fluroquinolones 2Fluroquinolones 2
Fluroquinolones 2
VIJAI KUMAR
 
Quinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones PharmacologyQuinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones Pharmacology
Koppala RVS Chaitanya
 
Antimycobacterial
AntimycobacterialAntimycobacterial
Antimycobacterial
Ahmad AlJifri
 
Quinolones & Fluoroquinolones
Quinolones & FluoroquinolonesQuinolones & Fluoroquinolones
Quinolones & Fluoroquinolones
Dr Resu Neha Reddy
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
Dr. Pramod B
 
Fluroquinolones 01 01-19
Fluroquinolones 01 01-19Fluroquinolones 01 01-19
Fluroquinolones 01 01-19
uma advani
 
Quinolones
QuinolonesQuinolones
Quinolones
Shehnazkhan31
 
Quinolones
QuinolonesQuinolones
Quinolones
Zulcaif Ahmad
 
Antibiotics course quinolones
Antibiotics course quinolonesAntibiotics course quinolones
Antibiotics course quinolones
mohamednassar1
 
Anti tb drugs
Anti tb drugsAnti tb drugs
Anti tb drugs
Dr Pralhad Patki
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
Medico15
 
Anti tubercular drugs PHARMACOLOGY REVISION NOTES
Anti tubercular drugs PHARMACOLOGY REVISION NOTES Anti tubercular drugs PHARMACOLOGY REVISION NOTES
Anti tubercular drugs PHARMACOLOGY REVISION NOTES
TONY SCARIA
 
Tuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugsTuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugs
Narasimha Kumar G V
 
Quinolones
QuinolonesQuinolones
Quinolones
Dr Shah Murad
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
shabeel pn
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
Raqshan Jabeen
 
Antibiotics course. 1-Quinolones
Antibiotics course. 1-QuinolonesAntibiotics course. 1-Quinolones
Antibiotics course. 1-Quinolones
Pharmacist Development Group
 

What's hot (20)

Quinolones
QuinolonesQuinolones
Quinolones
 
Anti TB drugs and Treatment of tuberculosis satya
Anti TB drugs and Treatment of tuberculosis   satya  Anti TB drugs and Treatment of tuberculosis   satya
Anti TB drugs and Treatment of tuberculosis satya
 
Quinolone resistance
Quinolone resistanceQuinolone resistance
Quinolone resistance
 
Fluroquinolones 2
Fluroquinolones 2Fluroquinolones 2
Fluroquinolones 2
 
Quinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones PharmacologyQuinolones fluoroquinolones Pharmacology
Quinolones fluoroquinolones Pharmacology
 
Antimycobacterial
AntimycobacterialAntimycobacterial
Antimycobacterial
 
Quinolones & Fluoroquinolones
Quinolones & FluoroquinolonesQuinolones & Fluoroquinolones
Quinolones & Fluoroquinolones
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
 
Fluroquinolones 01 01-19
Fluroquinolones 01 01-19Fluroquinolones 01 01-19
Fluroquinolones 01 01-19
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Antibiotics course quinolones
Antibiotics course quinolonesAntibiotics course quinolones
Antibiotics course quinolones
 
Anti tb drugs
Anti tb drugsAnti tb drugs
Anti tb drugs
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
Anti tubercular drugs PHARMACOLOGY REVISION NOTES
Anti tubercular drugs PHARMACOLOGY REVISION NOTES Anti tubercular drugs PHARMACOLOGY REVISION NOTES
Anti tubercular drugs PHARMACOLOGY REVISION NOTES
 
Tuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugsTuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugs
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
 
Antibiotics course. 1-Quinolones
Antibiotics course. 1-QuinolonesAntibiotics course. 1-Quinolones
Antibiotics course. 1-Quinolones
 

Similar to Fluroquinolones.. Dr. kiran g. piparva

Quinolones &UTI
Quinolones &UTIQuinolones &UTI
Quinolones &UTI
Vijay Prasad Sangisetti
 
FLURO QUINOLONESfor MBBS studentsppt.ppt
FLURO QUINOLONESfor MBBS studentsppt.pptFLURO QUINOLONESfor MBBS studentsppt.ppt
FLURO QUINOLONESfor MBBS studentsppt.ppt
Mangaiarkkarasi
 
3.ppt
3.ppt3.ppt
3 (1).ppt, Quinolones, Antibiotcs, Pharmacology
3 (1).ppt, Quinolones, Antibiotcs, Pharmacology3 (1).ppt, Quinolones, Antibiotcs, Pharmacology
3 (1).ppt, Quinolones, Antibiotcs, Pharmacology
MaggieAlex1
 
3.ppt
3.ppt3.ppt
Quinolone
QuinoloneQuinolone
Quinolone
Chintan Doshi
 
resistanttb-160504062328.pdf how to manage
resistanttb-160504062328.pdf how to manageresistanttb-160504062328.pdf how to manage
resistanttb-160504062328.pdf how to manage
Lawrenceshamboko
 
Resistant tb
Resistant tbResistant tb
Resistant tb
Dr. Irfan Ahmad Khan
 
Quinolones
QuinolonesQuinolones
Quinolones
Shubham Marbade
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
Zainab&Sons
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
Zainab&Sons
 
URINARY ANTICEPTICS.ppt
URINARY ANTICEPTICS.pptURINARY ANTICEPTICS.ppt
URINARY ANTICEPTICS.ppt
OnamiEmmanuel
 
Quinolones and fluroquinolones
Quinolones and fluroquinolonesQuinolones and fluroquinolones
Quinolones and fluroquinolones
zeelmevada
 
Quinolones & fluoroquinolones
Quinolones & fluoroquinolonesQuinolones & fluoroquinolones
Quinolones & fluoroquinolones
Ameena Kadar
 
Sulfonamide
SulfonamideSulfonamide
Sulfonamide
Chintan Doshi
 
FLUOROQUINOLONES.pptx
FLUOROQUINOLONES.pptxFLUOROQUINOLONES.pptx
FLUOROQUINOLONES.pptx
SumeetDumbre
 
Pharmacology of antitubercular drugs
Pharmacology of antitubercular drugsPharmacology of antitubercular drugs
Pharmacology of antitubercular drugs
RAVISHANKARMANCHUKON
 
6.antibiotics in oral and maxillofacial surgery
6.antibiotics in oral and maxillofacial surgery6.antibiotics in oral and maxillofacial surgery
6.antibiotics in oral and maxillofacial surgery
Tejaswini498924
 
Antimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note AntimycobacterialAntimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note Antimycobacterial
IgweSolomon4
 
Quinolones.pptx
Quinolones.pptxQuinolones.pptx
Quinolones.pptx
Subramani Parasuraman
 

Similar to Fluroquinolones.. Dr. kiran g. piparva (20)

Quinolones &UTI
Quinolones &UTIQuinolones &UTI
Quinolones &UTI
 
FLURO QUINOLONESfor MBBS studentsppt.ppt
FLURO QUINOLONESfor MBBS studentsppt.pptFLURO QUINOLONESfor MBBS studentsppt.ppt
FLURO QUINOLONESfor MBBS studentsppt.ppt
 
3.ppt
3.ppt3.ppt
3.ppt
 
3 (1).ppt, Quinolones, Antibiotcs, Pharmacology
3 (1).ppt, Quinolones, Antibiotcs, Pharmacology3 (1).ppt, Quinolones, Antibiotcs, Pharmacology
3 (1).ppt, Quinolones, Antibiotcs, Pharmacology
 
3.ppt
3.ppt3.ppt
3.ppt
 
Quinolone
QuinoloneQuinolone
Quinolone
 
resistanttb-160504062328.pdf how to manage
resistanttb-160504062328.pdf how to manageresistanttb-160504062328.pdf how to manage
resistanttb-160504062328.pdf how to manage
 
Resistant tb
Resistant tbResistant tb
Resistant tb
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
Fluoroquinolones
FluoroquinolonesFluoroquinolones
Fluoroquinolones
 
URINARY ANTICEPTICS.ppt
URINARY ANTICEPTICS.pptURINARY ANTICEPTICS.ppt
URINARY ANTICEPTICS.ppt
 
Quinolones and fluroquinolones
Quinolones and fluroquinolonesQuinolones and fluroquinolones
Quinolones and fluroquinolones
 
Quinolones & fluoroquinolones
Quinolones & fluoroquinolonesQuinolones & fluoroquinolones
Quinolones & fluoroquinolones
 
Sulfonamide
SulfonamideSulfonamide
Sulfonamide
 
FLUOROQUINOLONES.pptx
FLUOROQUINOLONES.pptxFLUOROQUINOLONES.pptx
FLUOROQUINOLONES.pptx
 
Pharmacology of antitubercular drugs
Pharmacology of antitubercular drugsPharmacology of antitubercular drugs
Pharmacology of antitubercular drugs
 
6.antibiotics in oral and maxillofacial surgery
6.antibiotics in oral and maxillofacial surgery6.antibiotics in oral and maxillofacial surgery
6.antibiotics in oral and maxillofacial surgery
 
Antimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note AntimycobacterialAntimycobacterial drugs note Antimycobacterial
Antimycobacterial drugs note Antimycobacterial
 
Quinolones.pptx
Quinolones.pptxQuinolones.pptx
Quinolones.pptx
 

Recently uploaded

Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
Bisnar Chase Personal Injury Attorneys
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
NgcHiNguyn25
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
simonomuemu
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 

Recently uploaded (20)

Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 

Fluroquinolones.. Dr. kiran g. piparva

  • 1. Dr. kiran G.piparva Assistant professor, Pharmacology department P . D. U. Government medical college, Rajkot
  • 2. Contents…… • Introduction • Chemical structure • Classification • Antibacterial spectrum • Mechanism of action • Mechanism of resistance • Individual drugs
  • 3. • Synthetic antimicrobial agent • Having quinolone structure • Primarily active against gram negative bacteria • First member is NALIDIXIC ACID
  • 4. Breakthrough 1980- • Fluorination of quinolone structure at 6th position and addition of piperazine at 7th position resulting derivative called- “FLUROQUINOLONES”
  • 5. Development of FQs…… • 1960s – Nalidixic acid • 1970s – Cinoxacin and Rosoxcin • 1980s – Norfloxacin , Ciprofloxacin, Ofloxacin • 1990s – Lomefloxacin, Sparfloxacin • 2000s – Lovofloxacin, Gatifloxacin, Trovafloxacin , Moxifloxacin, Gemifloxacin
  • 6. FQs First generation One FLUORO substitution Effective against gram-ve organism Second generation - ADDITIONAL FLUORO and other substitutions .. Antimicrobial spectrum extendto gram +ve and anaerobes
  • 8. Bacterial DNA gyrase Subunit B Subunit A Site of action Mechanism of action of FQ…. Positive supercoiling Negative supercoiling
  • 9. Mechanism of action of FQ Gram -ve Gram +ve
  • 10.  Less likely & very slow to develop  Reduced permeability  Increased efflux  Chromosomal mutation producing a DNA gyrase/ topoisomerase IV with reduced affinity for FQs. Mechanism of Resistant
  • 11. •For individual drugs… DIFFERENCES…. • Antimicrobial spectrum • Pharmacokinetic profile • ADR
  • 12. CIPROFLOXACIN (prototype) • Most potent 1st generation FQ • Spectrum : • Aerobic gram – ve bacilli- Enterobacteriaceae and Neisseria
  • 13. Antibiotic spectrum  Higley susceptible Gram -ve bacilli Gram -ve cocci -E.Coli - Neisseria -Salmonella -H. influenzae -Shigella -H, ducreyi -Proteus -Compylobector - K. pneumoniae jejuni  Moderately susceptible -Atypical organisms -Pseudomonas aeruginosa - Anthracis - Brucella - Chlamydia pneumophila - Listeria - Mycoplasma - Mycobacterium - Staph epidermidis Low or variable susceptibility (gm+Ve) - Strep. Pyrogens - Strep. Faecalis - Strep. Pneumoniae - MRSA - Mycobact. Kansasii - MAC RESISTANT : ANAEROBES
  • 14. Pharmacokinetics • Absorption: good with empty stomach • Good tissue penetrability • Renal excretion : required dose reduction in kidney damage
  • 15. ADR of FQ… • Good safety record…..Mild ADRs • GIT: N/V/A, bad taste • CNS: Dizziness, headache, restlessness, anxiety, insomnia, impairment of concentration, dexterity- seizure when high dose or predisposing factors • HST: hypersensitivity reaction- rash pruritis, photosensitivity, urticaria, swellings. • Tendonitis and tendon rupture: higher in age above 60yrs, patients receiving corticosteroids. Children, seizure, photosensitivity While driving C/I : pregnancy
  • 16. Drug Interactions • Absorption: Other drugs reduce absorption of FQs : Antacids, sucralfate and iron salts • Norfox/ ciproflox/ pefloxacin raises theophylline, caffeine and warfarin concentration – Second generation are safe • NSAIDs may enhance the CNS toxicity of FQs; seizures are reported
  • 17. Important features of FQs……… Bactericidal Rapid action Post antibiotic effect Mutational resistance is low Susceptible to Penicillin , cephalosporin, aminoglycoside resistant bacteria Activity is pH dependent – reduced activity at acidic pH
  • 18. Therapeutic uses of FQs….. • Ciprofloxacin is highly effective because…..  Wide spectrum  Bactericidal activity  Oral efficacy  Good tolerability  Best for gram –ve infections  EMPIRICAL THERAPY DOSE:
  • 19. Gram negative infections Urinary track infection Bacterial gastroenteritis Typhoid fever Bone & soft tissue, gynecological and wound infection Gram negative septicemia Conjunctivitis Gonorrhoea Meningitis
  • 20. • Other infections: • Chancroid • Anthrax • Respiratory infection • Tuberculosis • Prophylaxis
  • 21. Therapeutic uses……. 1. Urinary tract infection(UTI) • FQ are superior to Trimethoprim-sulfamethoxazole • Good concentration in urine • High cure rate even in complicated UTI • All FQ are equally effective 2. Bacterial gastroenteritis: Empirical therapy- most common 3. Gonorrhoea: 100% curative in PPNG/ NPPNG- not used now 4. Bone soft tissue, gynaecological and wound infection: high cure rate is obtained with prolonged Rx (6-8wk) with high dose (750mgBD)
  • 22. 5. Typhoid fever • First line drugs • Ciprofloxacin is the drug of choice • 750mg BD orally or 200mg I.V. 12 hrly for 10-14 days Other options: • Ceftriaxone: fastest acting bactericidal, prevent relapse and carrier state, preferred over FQs in children, pregnant women & FQ resistant cases • Fluroquinolones: equally efficacious alternative ceftriaxone • Azithromycin: 2nd line alternative in multidrug resistant typhoid • Chloramphenicol: Resistant and unreliable • Cotrimoxazole: Resistant, rarely used.
  • 23. 6. Respiratory infections • Not as primary drug • DOC only for Atypical pneumonia due to Mycoplasma, legionella, H. influenzas, Chlamydia pneumonia • 2nd generation (Levofloxacin/ Gemifloxacin/ Moxifloxacin) – used 7. Tuberculosis • Moxifloxacin/ levofloxacin : 2nd line antitubercular drug & for combination drugs in MDR TB • Ciprofloxacin most active against MAC 8. Meningitis: Only for gm –ve bacterial meningitis especially in immunocompromised patients
  • 24. Properties of 1st generation FQs • No activity against S. Pneumoniae & anaerobes • No significant CNS concentration • Short action – twice daily dosing • DI: Raises warfarin and theophylline concentration Common to Ciproflox/ Oflox / Pefloxacin
  • 25. Properties of 2nd generation FQs • Spectrum: Active against Gm +ve bacteria & anaerobes • PK: Longer action – OD- good compliance • CNS concentration is poor • NO DI: Levoflox/ sparflox do not interact with warfarin and theophylline • ADR: • Prolongs QT interval/ Phototoxicity – sparflox/gatiflox/moxiflox/gemiflox
  • 26. • Pefloxacin: • Better PK- lipid soluble, long t1/2- better CSF concentration • Metabolized to norfloxacin- dose adjustment required in liver disease but NOT in renal insufficiency • Ofloxacin: • More active on strep. Pyogenes and gram+ve / anaerobes, chlamydia, Mycoplasma, mycobacterium • MDR TB: Alternative therapy for multidrug resistant tuberculosis
  • 27. • Levofloxacin • Levo isomer of ofloxacin - Good PK- 100% bioavailability orally – long half life- OD- NO Drug interaction - Primary indication: - CAP- community acquired pneumonia, pyelonephritis, prostatis, skin/ soft tissue infection - MDR TB : 2nd line antitubercular drug- combined regimen for MDR TB • Moxifloxacin: • MDR TB : Most potent against M. tuberculosis- used in MDR TB • Should not given to predisposed to seizure- QT prolongation 2nd generation FQs
  • 28. • Sparfloxacin: • 2nd generation difluorinated quinolones • Phototoxic, QT prolongation • Lomefloxacin • 2nd generation difluorinated - higher phototoxicity- Q-T prolongation • Gemifloxacin: • Broad spectrum/ aerobic/ resistant orgasnim • QT prolongation, DI QT PROLONGATION, PHTOTOXICITY
  • 29. • Prulifloxacin Prodrug- Good spectrum- Good PK NO QT - PROLONGATION • Pazufloxacin: • Only injectable formulation as “ Mesylate” • Rarely seizure- limit dose • Balofloxacin • Marketed only in India and few other countries
  • 31. Pharmacokinetics Absorption Distribution Metabolism Elimination Ciprofloxacin is well absorbed on empty stomach F= 70-95% except norfloxacin – 40% Excellent tissue penetration (lungs, sputum, prostate , muscle, bone) Poor penetration in brain and eyes Pefloxacin and Moxifloxacin , Trovafloxacin are metabolised by liver- require dose reduction in hepatic dysfunction (PMT) Most Quinolones are cleared by kidney - require dose reduction in renal dysfunction • Clinically significant post antibiotic effect (2-6 hours) • Sparfloxacin has longest action (18-20 hrs) • 1st generation drugs given twice a day – • 2nd generation drugs once only
  • 32. Some withdrawn FQs • Gatifloxacin – Dysglycemia • Lomiflxacin/ sparfloxacin – photosensitivity & QT prolongation • Trovafloxacin – Hepatotoxicity • Grepafloxacin – Cardiotoxicity